Apreo Health Raises $130M in Series B

Apreo Health has successfully raised $130M in a Series B led by Bain Capital Life Sciences, Norwest Venture Partners.

Company Overview

Apreo Health is a HealthTech company headquartered in Menlo Park, CA, founded in 2018 with 90+ employees.

Clinical-stage company developing novel treatment for severe emphysema

Fundraising Details

• Amount Raised: $130M
• Round Type: Series B
• Date: 2025-09-17
• Investors: Bain Capital Life Sciences, Norwest Venture Partners

About Apreo Health

Clinical-stage company developing novel treatment for severe emphysema The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: Menlo Park, CA
• Founded: 2018
• Team Size: 90+
• Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Apreo Health's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Apreo Health's successful fundraising reflects the strong fundamentals and growth potential in this space.

Looking Ahead

With this new capital, Apreo Health is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-09-17. For more information about Apreo Health, visit their headquarters at Menlo Park, CA.